Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Antivirals-Covid-19-HIV/JCV/HBV/HCV/Zika/Ebola by Palisades Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Antivirals-Covid-19-HIV/JCV/HBV/HCV/Zika/Ebola is under clinical development by Palisades Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to...
PT-150 by Palisades Therapeutics for Pancreatic Cancer: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
PT-150 by Palisades Therapeutics for Alcohol Dependence: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase II for Alcohol Dependence. According to GlobalData, Phase...
PT-150 by Palisades Therapeutics for Glioblastoma Multiforme (GBM): Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
PT-150 by Palisades Therapeutics for Prostate Cancer: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Prostate Cancer. According to GlobalData, Phase...
PT-150 by Palisades Therapeutics for Ovarian Cancer: Likelihood of Approval
PT-150 is under clinical development by Palisades Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...